Clinical Trial Update: Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating an allogeneic stem cell transplant regimen using clofarabine, cytarabine (Ara-C), and total body irradiation for acute lymphoblasti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clofarabine (clofarabine)

Snippet

Sponsor: New York Medical College | Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Phase 1, Phase 2 | Status: COMPLETED